Collaborative Multiple Sclerosis Research Meetings
The Multiple Sclerosis Center provides ongoing opportunities for partnership between UAB’s nationally-renowned MS researchers and other research faculty who have complementary research interests and expertise. This collaborative effort aims to foster cross-disciplinary communication & thinking in order to develop and evaluate novel therapies that can manipulate the immune system to better treat MS. The project also has a strong educational component and provides engagement & training opportunities for graduate students, post-doctoral fellows and medical residents. Launched in 2010 with UAB’s receipt of the National Multiple Sclerosis Society’s (NMSS) prestigious Collaborative Multiple Sclerosis Research Center Award, meetings continue to be held monthly and are open to all interested faculty & staff.
MS & Neuroimmunology Journal Club
Monthly Journal Club Meetings through the MSC bring together clinicians, statisticians, and basic researchers to discuss recent literature pertaining to MS and neuroimmunology.
Emphases alternate between clinical and basic science topics with opportunities to evaluate the study design, applicability of the findings, and necessary future study to strengthen or weaken the data.
Center for Clinical and Translational Science Training Programs
The UAB Center for Clinical and Translational Science (CCTS) offers a variety of courses and workshops designed to educate clinician scientists in the conduct of clinical and translational workshop. One example includes the Clinical and Translational Science Training Program, a 6-month course in which trainees complete modules on clinical trials, epidemiology, biostatistics, ethics, and grant writing, among other topics.
UAB Multiple Sclerosis Symposium
Every two years, UAB hosts a regional MS Symposium to which clinicians and researchers from UAB and across the country are invited to present on MS-related topics. Prior
agendas & speakers have covered a variety of scientific and clinical areas pertinent to the treatment of the disease.